Heteroarylacetamide inhibitors of factor Xa
US7361672B2 · kind B2 · utility
1Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 2005 |
| Grant date | Apr 22, 2008 |
| Priority date | — |
| Expiry date | Feb 16, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention is concerned with novel heteroarylacetamides of formula (I)Rd—C(O)—N(Re)—Rc—CH2—C(O)—N(Ra)(Rb) (I)wherein Ra to Re are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.